These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

340 related items for PubMed ID: 34794069

  • 1. NTRK-Rearranged soft tissue neoplasms: A review of evolving diagnostic entities and algorithmic detection methods.
    Surrey LF, Davis JL.
    Cancer Genet; 2022 Jan; 260-261():6-13. PubMed ID: 34794069
    [Abstract] [Full Text] [Related]

  • 2. Pan-Trk Immunohistochemistry Identifies NTRK Rearrangements in Pediatric Mesenchymal Tumors.
    Rudzinski ER, Lockwood CM, Stohr BA, Vargas SO, Sheridan R, Black JO, Rajaram V, Laetsch TW, Davis JL.
    Am J Surg Pathol; 2018 Jul; 42(7):927-935. PubMed ID: 29683818
    [Abstract] [Full Text] [Related]

  • 3. Detection of NTRK fusions in glioblastoma: fluorescent in situ hybridisation is more useful than pan-TRK immunohistochemistry as a screening tool prior to RNA sequencing.
    Bourhis A, Caumont C, Quintin-Roué I, Magro E, Dissaux G, Remoué A, Le Noac'h P, Douet-Guilbert N, Seizeur R, Tyulyandina A, Schick U, Merlio JP, Marcorelles P, Cappellen D, Uguen A.
    Pathology; 2022 Feb; 54(1):55-62. PubMed ID: 34518039
    [Abstract] [Full Text] [Related]

  • 4. Infantile NTRK-associated Mesenchymal Tumors.
    Davis JL, Lockwood CM, Albert CM, Tsuchiya K, Hawkins DS, Rudzinski ER.
    Pediatr Dev Pathol; 2018 Feb; 21(1):68-78. PubMed ID: 28683589
    [Abstract] [Full Text] [Related]

  • 5. ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical research.
    Marchiò C, Scaltriti M, Ladanyi M, Iafrate AJ, Bibeau F, Dietel M, Hechtman JF, Troiani T, López-Rios F, Douillard JY, Andrè F, Reis-Filho JS.
    Ann Oncol; 2019 Sep 01; 30(9):1417-1427. PubMed ID: 31268127
    [Abstract] [Full Text] [Related]

  • 6. Broadening the spectrum of NTRK rearranged mesenchymal tumors and usefulness of pan-TRK immunohistochemistry for identification of NTRK fusions.
    Brčić I, Godschachner TM, Bergovec M, Igrec J, Till H, Lackner H, Scheipl S, Kashofer K, Brodowicz T, Leithner A, Szkandera J, Liegl-Atzwanger B.
    Mod Pathol; 2021 Feb 01; 34(2):396-407. PubMed ID: 32860002
    [Abstract] [Full Text] [Related]

  • 7. Soft tissue tumors characterized by a wide spectrum of kinase fusions share a lipofibromatosis-like neural tumor pattern.
    Kao YC, Suurmeijer AJH, Argani P, Dickson BC, Zhang L, Sung YS, Agaram NP, Fletcher CDM, Antonescu CR.
    Genes Chromosomes Cancer; 2020 Oct 01; 59(10):575-583. PubMed ID: 32506523
    [Abstract] [Full Text] [Related]

  • 8. Clinicopathological findings of pediatric NTRK fusion mesenchymal tumors.
    Kang J, Park JW, Won JK, Bae JM, Koh J, Yim J, Yun H, Kim SK, Choi JY, Kang HJ, Kim WS, Shin JH, Park SH.
    Diagn Pathol; 2020 Sep 21; 15(1):114. PubMed ID: 32957984
    [Abstract] [Full Text] [Related]

  • 9. NTRK-rearranged Cervical Sarcoma: Expanding the Clinicopathologic Spectrum.
    Hodgson A, Pun C, Djordjevic B, Turashvili G.
    Int J Gynecol Pathol; 2021 Jan 21; 40(1):73-77. PubMed ID: 32044823
    [Abstract] [Full Text] [Related]

  • 10. Identification of NTRK gene fusions in lung adenocarcinomas in the Chinese population.
    Zhao R, Yao F, Xiang C, Zhao J, Shang Z, Guo L, Ding W, Ma S, Yu A, Shao J, Zhu L, Han Y.
    J Pathol Clin Res; 2021 Jul 21; 7(4):375-384. PubMed ID: 33768710
    [Abstract] [Full Text] [Related]

  • 11. NTRK fusions and Trk proteins: what are they and how to test for them.
    Weiss LM, Funari VA.
    Hum Pathol; 2021 Jun 21; 112():59-69. PubMed ID: 33794242
    [Abstract] [Full Text] [Related]

  • 12. Pan-Trk Immunohistochemistry Is an Efficient and Reliable Screen for the Detection of NTRK Fusions.
    Hechtman JF, Benayed R, Hyman DM, Drilon A, Zehir A, Frosina D, Arcila ME, Dogan S, Klimstra DS, Ladanyi M, Jungbluth AA.
    Am J Surg Pathol; 2017 Nov 21; 41(11):1547-1551. PubMed ID: 28719467
    [Abstract] [Full Text] [Related]

  • 13. Diagnostic testing approaches for the identification of patients with TRK fusion cancer prior to enrollment in clinical trials investigating larotrectinib.
    Rudzinski ER, Hechtman J, Roy-Chowdhuri S, Rudolph M, Lockwood CM, Silvertown J, Wierzbinska J, Shen K, Norenberg R, Nogai H, Hong DS, Drilon A, Laetsch TW.
    Cancer Genet; 2022 Jan 21; 260-261():46-52. PubMed ID: 34929613
    [Abstract] [Full Text] [Related]

  • 14. The histologic spectrum of soft tissue spindle cell tumors with NTRK3 gene rearrangements.
    Suurmeijer AJ, Dickson BC, Swanson D, Zhang L, Sung YS, Huang HY, Fletcher CD, Antonescu CR.
    Genes Chromosomes Cancer; 2019 Nov 21; 58(11):739-746. PubMed ID: 31112350
    [Abstract] [Full Text] [Related]

  • 15. NTRK Fusions Define a Novel Uterine Sarcoma Subtype With Features of Fibrosarcoma.
    Chiang S, Cotzia P, Hyman DM, Drilon A, Tap WD, Zhang L, Hechtman JF, Frosina D, Jungbluth AA, Murali R, Park KJ, Soslow RA, Oliva E, Iafrate AJ, Benayed R, Ladanyi M, Antonescu CR.
    Am J Surg Pathol; 2018 Jun 21; 42(6):791-798. PubMed ID: 29553955
    [Abstract] [Full Text] [Related]

  • 16. The oncogenic roles of NTRK fusions and methods of molecular diagnosis.
    Aref-Eshghi E, Lin F, Li MM, Zhong Y.
    Cancer Genet; 2021 Nov 21; 258-259():110-119. PubMed ID: 34710798
    [Abstract] [Full Text] [Related]

  • 17. Recurrent BRAF Gene Fusions in a Subset of Pediatric Spindle Cell Sarcomas: Expanding the Genetic Spectrum of Tumors With Overlapping Features With Infantile Fibrosarcoma.
    Kao YC, Fletcher CDM, Alaggio R, Wexler L, Zhang L, Sung YS, Orhan D, Chang WC, Swanson D, Dickson BC, Antonescu CR.
    Am J Surg Pathol; 2018 Jan 21; 42(1):28-38. PubMed ID: 28877062
    [Abstract] [Full Text] [Related]

  • 18. Identifying patients with NTRK fusion cancer.
    Solomon JP, Benayed R, Hechtman JF, Ladanyi M.
    Ann Oncol; 2019 Nov 21; 30 Suppl 8():viii16-viii22. PubMed ID: 32223934
    [Abstract] [Full Text] [Related]

  • 19. Detection of NTRK1/3 Rearrangements in Papillary Thyroid Carcinoma Using Immunohistochemistry, Fluorescent In Situ Hybridization, and Next-Generation Sequencing.
    Lee YC, Chen JY, Huang CJ, Chen HS, Yang AH, Hang JF.
    Endocr Pathol; 2020 Dec 21; 31(4):348-358. PubMed ID: 32880785
    [Abstract] [Full Text] [Related]

  • 20. Elaboration of NTRK-rearranged colorectal cancer: Integration of immunoreactivity pattern, cytogenetic identity, and rearrangement variant.
    Wu S, Liu Y, Shi X, Zhou W, Zeng X.
    Dig Liver Dis; 2023 Dec 21; 55(12):1757-1764. PubMed ID: 37142453
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.